Tanabe Pharma America Completes Transfer of RADICAVA Business to Shionogi Tanabe Pharma America finalizes the transfer of RADICAVA to Shionogi, ensuring the therapy's continued growth and support for ALS patients.

Tanabe Pharma America Completes Transfer of RADICAVA Business to Shionogi #USA #Jersey_City #RADICAVA #Shionogi #Tanabe_Pharma

Tanabe Pharma America to Present Innovative ALS Research at 2026 MDA Conference Tanabe Pharma America will share findings on ALS research, including pivotal studies on RADICAVA ORS and digital health solutions at the 2026 MDA Conference in Orlando.

Tanabe Pharma America to Present Innovative ALS Research at 2026 MDA Conference #United_States #Orlando #ALS_Research #MDA_Conference #Tanabe_Pharma

Tanabe Pharma America Transfers RADICAVA® Business to Shionogi for Growth and Innovation Tanabe Pharma America has announced the transfer of RADICAVA® business to Shionogi, aiming for enhanced focus on growth and solutions for ALS patients.

Tanabe Pharma America Transfers RADICAVA® Business to Shionogi for Growth and Innovation #United_States #Jersey_City #RADICAVA #Shionogi #Tanabe_Pharma

Promoting a Comprehensive Understanding of Obesity and Obesity Disorders through Interactive Workshops Japan Eli Lilly and Tanabe Pharma launched an innovative program to promote awareness of obesity and its misconceptions through engaging workshops.

Promoting a Comprehensive Understanding of Obesity and Obesity Disorders through Interactive Workshops #Japan #Kobe #Tanabe_Pharma #Obesity_Disorders #Japan_Eli_Lilly

Tanabe Pharma America Shares Promising ALS Research Insights at MNDA Symposium Tanabe Pharma America has unveiled intriguing preclinical findings on edaravone's role in ALS during the MNDA International Symposium, signaling potential advances.

Tanabe Pharma America Shares Promising ALS Research Insights at MNDA Symposium #USA #San_Diego #ALS_Research #Tanabe_Pharma #Edaravone

Mitsubishi Tanabe Pharma America Transitions to Tanabe Pharma America for Global Growth Mitsubishi Tanabe Pharma America has renamed itself Tanabe Pharma America as part of a strategic shift, emphasizing innovation and global commitment.

Mitsubishi Tanabe Pharma America Transitions to Tanabe Pharma America for Global Growth #United_States #Jersey_City #ALS_Treatment #Tanabe_Pharma #MTPA